IRVINE, Calif., July 13, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced that Bob Rankin will be joining the company as its chief financial officer beginning July […]
Author: Ken Dropiewski
Zebra Medical Vision Announces FDA 510(k) Clearance of Its Coronary Calcium Algorithm
SHEFAYIM, Israel–(BUSINESS WIRE)–Zebra Medical Vision (http://zebra-med.com/) announces today it has received 510(k) clearance for its Coronary Calcium Scoring algorithm. The algorithm, capable of automatically calculating a patient’s Agatston equivalent coronary calcium score from ECG gated CT scan, provides physicians with important data used in the assessment of the risk for coronary […]
Didier Miraton joins CardioRenal’s supervisory board
Strasbourg, France, July 10, 2018 – CardioRenal, a major new player in telemedicine for patients with severe heart failure, today announces the arrival of Didier Miraton as an independent member of its supervisory board. Mr. Miraton boasts both substantial life sciences and industrial experience, gained as CEO of the Michelin […]
Sernova Announces $2,000,000 First Closing of Private Placement
LONDON, Ontario, July 16, 2018 (GLOBE NEWSWIRE) — Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) is pleased to announce that it closed $2,000,000 of its non-brokered private placement announced on June 26, 2018. In addition, as the Company has received over-subscriptions of $404,000, it is increasing the total […]
Neovasc Announces Filing of “Administrative” Prospectus Supplement Relating to Expiry of Prior Shelf Prospectus / Registration Statement
VANCOUVER, July 16, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that, in connection with its new final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with securities regulatory authorities in the provinces of British Columbia, Alberta, Saskatchewan, Manitoba and Ontario (the “Provinces”) and its corresponding shelf registration statement on Form […]
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
FRANKLIN LAKES, N.J., July 9, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of TVA Medical, Inc., a company that develops minimally invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis. In the U.S. alone, […]
MERIT MEDICAL NAMED EXCLUSIVE DISTRIBUTOR OF Q50® PLUS
SALT LAKE CITY, Utah – July 9, 2018 – Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, has been named the exclusive global distributor of the Q50® PLUS Stent Graft […]
CathWorks Receives CPT Code for New Wire-Free, Intraprocedural FFR Measurements to Optimize PCI Therapy Decisions
KFAR-SABA, Israel–(BUSINESS WIRE)–CathWorks announced the approval of a new CPT code 0523T for non-invasive, 3D FFRangio™ enabled interpretation of possible atherosclerotic stenosis during coronary angiography interventions. The code issuance is a major step forward in helping physicians objectively and cost-effectively determine if PCI (percutaneous coronary intervention) is indicated and revascularization […]
Cagent Vascular Raises $11.87M to Fund the Growth and Expansion of the Serranator Family of Percutaneous Transluminal Angioplasty (PTA) Serration Balloon Catheters
WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular®, a developer of next generation angioplasty balloons using proprietary serration technology, announced the completion of $11.87 million in Series B funding. The round was led by two strategic investors including one that participated in the Series A financing. Additional participants included Balestier Investments, Ben Franklin Technology […]
BD Shares Progress towards Achieving 2020 Sustainability Goals
FRANKLIN LAKES, N.J., July 12, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that support the company’s 2020 Sustainability Goals. BD’s sustainability strategy is driven by its purpose – advancing the world of health – and focuses on […]



